EMPAGEN TRIO 10/5/1000MG TAB

EMPAGEN TRIO combines three powerful antidiabetic agents in a single tablet for comprehensive blood sugar management. Each tablet contains Empagliflozin 10mg, Linagliptin 5mg, and Metformin 1000mg—working synergistically to improve glycemic control in type 2 diabetes patients. Empagliflozin promotes glucose excretion through urine, Linagliptin inhibits DPP-4 to enhance incretin activity, and Metformin reduces hepatic glucose production. This triple combination offers improved efficacy compared to dual therapies, helping patients achieve better HbA1c targets with simplified dosing. Ideal for patients requiring intensified diabetes management. Take as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight.